7-23299401-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138446.2(MALSU1):c.49C>T(p.Arg17Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000412 in 1,598,924 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138446.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MALSU1 | ENST00000466681.2 | c.49C>T | p.Arg17Cys | missense_variant | 1/4 | 1 | NM_138446.2 | ENSP00000419370.1 | ||
MALSU1 | ENST00000287543.4 | n.63C>T | non_coding_transcript_exon_variant | 1/3 | 2 | |||||
MALSU1 | ENST00000481564.1 | n.61C>T | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
MALSU1 | ENST00000479974.1 | n.411+252C>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000291 AC: 65AN: 222988Hom.: 0 AF XY: 0.000291 AC XY: 36AN XY: 123672
GnomAD4 exome AF: 0.000415 AC: 600AN: 1446564Hom.: 1 Cov.: 31 AF XY: 0.000417 AC XY: 300AN XY: 719500
GnomAD4 genome AF: 0.000381 AC: 58AN: 152360Hom.: 0 Cov.: 33 AF XY: 0.000389 AC XY: 29AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.49C>T (p.R17C) alteration is located in exon 1 (coding exon 1) of the MALSU1 gene. This alteration results from a C to T substitution at nucleotide position 49, causing the arginine (R) at amino acid position 17 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at